Disease-modifying anti-asthmatic drugs

Marek Lommatzsch; Guy G. Brusselle; G. Walter Canonica; David J. Jackson; Parameswaran Nair; Roland Buhl; Johann Christian Virchow

doi:10.1016/S0140-6736(22)00331-2

Disease-modifying anti-asthmatic drugs

Marek Lommatzsch, Guy G. Brusselle, G. Walter Canonica, David J. Jackson, Parameswaran Nair, Roland Buhl, Johann Christian Virchow

Peter Gorer Department of Immunobiology

Research output: Contribution to journal › Review article › peer-review

26 Citations (Scopus)

Original language	English
Pages (from-to)	1664-1668
Number of pages	5
Journal	Lancet (London, England)
Volume	399
Issue number	10335
DOIs	https://doi.org/10.1016/S0140-6736(22)00331-2
Publication status	Published - 23 Apr 2022

Access to Document

10.1016/S0140-6736(22)00331-2

Cite this

@article{e5beae8b4afb471089de8fde4c169828,

title = "Disease-modifying anti-asthmatic drugs",

author = "Marek Lommatzsch and Brusselle, {Guy G.} and Canonica, {G. Walter} and Jackson, {David J.} and Parameswaran Nair and Roland Buhl and Virchow, {Johann Christian}",

year = "2022",

month = apr,

day = "23",

doi = "10.1016/S0140-6736(22)00331-2",

language = "English",

volume = "399",

pages = "1664--1668",

journal = "Lancet (London, England)",

issn = "0140-6736",

publisher = "Elsevier",

number = "10335",

}

TY - JOUR

T1 - Disease-modifying anti-asthmatic drugs

AU - Lommatzsch, Marek

AU - Brusselle, Guy G.

AU - Canonica, G. Walter

AU - Jackson, David J.

AU - Nair, Parameswaran

AU - Buhl, Roland

AU - Virchow, Johann Christian

PY - 2022/4/23

Y1 - 2022/4/23

UR - http://www.scopus.com/inward/record.url?scp=85128802397&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)00331-2

DO - 10.1016/S0140-6736(22)00331-2

M3 - Review article

C2 - 35461560

AN - SCOPUS:85128802397

SN - 0140-6736

VL - 399

SP - 1664

EP - 1668

JO - Lancet (London, England)

JF - Lancet (London, England)

IS - 10335

ER -

Disease-modifying anti-asthmatic drugs

Access to Document

Other files and links

Cite this